本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Biohaven Pharmaceutical Holding Co Ltd.

12.34
-0.3000-2.37%
盤後12.430.0900+0.73%19:30 EDT
成交量:308.29萬
成交額:3,752.56萬
市值:18.56億
市盈率:-2.75
高:12.67
開:12.57
低:11.96
收:12.64
52周最高:18.57
52周最低:7.48
股本:1.50億
流通股本:1.18億
量比:0.81
換手率:2.61%
股息:- -
股息率:- -
每股收益(TTM):-4.4800
每股收益(LYR):-6.8648
淨資產收益率:-799.46%
總資產收益率:-71.98%
市淨率:151.87
市盈率(LYR):-1.80

資料載入中...

2023/10/06

重要事件披露

Form 8-K - Current report
2023/10/03

重要事件披露

Form 8-K - Current report
2023/09/27

重要事件披露

Form 8-K - Current report
2023/07/31

重要事件披露

Form 8-K - Current report
2023/07/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/29

重要事件披露

Form 8-K - Current report
2023/05/31

重要事件披露

Form 8-K - Current report
2023/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/12

重要事件披露

Form 8-K - Current report
2022/10/04

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2022/10/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

重要事件披露

8-K - Current report
2022/09/29

重要事件披露

8-K - Current report
2022/09/27

重要事件披露

8-K - Current report
2022/09/23

重要事件披露

8-K - Current report
2022/09/23

重要事件披露

8-K - Current report